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Significant efforts have been devoted in the last twenty years to developing compounds that
can interfere with the aggregation pathways of proteins related to misfolding disorders,
including Alzheimer’s and Parkinson’s diseases. However, no disease-modifying drug has
become available for clinical use to date for these conditions. One of the main reasons for this
failure is the incomplete knowledge of the molecular mechanisms underlying the process by
which small molecules interact with protein aggregates and interfere with their aggregation
pathways. Here, we leverage the single molecule morphological and chemical sensitivity of
infrared nanospectroscopy to provide the first direct measurement of the structure and
interaction between single Aβ42 oligomeric and fibrillar species and an aggregation inhibitor,
bexarotene, which is able to prevent Aβ42 aggregation in vitro and reverses its neurotoxicity
in cell and animal models of Alzheimer’s disease. Our results demonstrate that the carboxyl
group of this compound interacts with Aβ42 aggregates through a single hydrogen bond.
These results establish infrared nanospectroscopy as a powerful tool in structure-based drug
discovery for protein misfolding diseases.
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A lzheimer’s disease (AD) is characterised by memory lossand cognitive impairment. AD is the primary cause ofdementia, which affects currently over 50 million people
worldwide, a number expected to exceed 150 million by 2050
(refs. 1–3). The self-assembly of the 42-residue isoform of the
amyloid-β (Aβ) peptide into intractable aggregates is considered
to be at the core of the molecular pathways leading to AD3–5. It is
therefore important to understand at the molecular level the
aggregation process of Aβ42 in order to develop effective ther-
apeutic strategies that aim at inhibiting its self-assembly.
Great efforts have been devoted in the last 20 years to under-
stand the molecular basis of this devastating disorder and to
develop small molecules that could interfere with the aggregation
pathway of Aβ42 (refs. 6–12). Indeed, disease-modifying small
molecules represent c.a. one-third of the registered trials, in which
anti-Aβ therapies dominate13. However, despite these efforts, no
compound has entered the clinical use to date13,14.
These repeated failures are in part related to an incomplete
understanding of the molecular mechanisms underlying the
process by which small molecules interact with protein aggregates
and how they interfere with the pathways of aggregation. It is
increasingly recognised that inhibiting Aβ aggregation per se
could have unexpected consequences on the toxicity, as it could
not only decrease it but also leave it unaffected, or even increase
it15. This complexity is due to the non-linear nature of the
aggregation network, in which neurotoxic small oligomeric
intermediates16–20 can be formed in a variety of ways, some of
which highly sensitive to small perturbation. Therefore, promis-
ing effective therapeutic strategies must be aimed at targeting
precise species in a controlled intervention during the aggregation
process.
We recently described a drug discovery strategy based on the
accurate characterisation of the effects of small molecules on the
kinetics of Aβ aggregation21. This strategy exploits the power of
chemical kinetics22,23, in which the effect of small molecules on
the rates of specific microscopic steps in Aβ42 aggregation can be
determined quantitatively. Using this strategy, we identified an
FDA-approved anti-cancer drug, bexarotene, which was found to
delay substantially the aggregation of Aβ42 and to reduce the
associated toxicity in vivo21,24. Bexarotene delays the aggregation
of Aβ42 in a concentration-dependent manner by inhibiting
primary and secondary pathways21. Although a kinetic under-
standing of the molecular mechanism by which small molecules
affect Aβ aggregation has been achieved, the chemical interac-
tions and the structural information on Aβ species in the free and
bound forms to the small molecule remain to be unravelled. This
limitation is mainly due to the lack of experimental tools that
allow accurate direct measurements of the chemical and struc-
tural properties of individual species in a heterogeneous
population.
A breakthrough in the analysis of the chemical properties of
heterogeneous protein aggregation at the nanoscale has been
achieved with the development and application of atomic force
microscopy in combination with infrared nanospectroscopy
(AFM-IR; Fig. 1d)25–35. AFM-IR is becoming widely applicable in
biology since is capable of acquiring simultaneously morpholo-
gical, nanomechanical and nanoscale resolved chemical IR maps
and absorption spectra from protein aggregates, liquid–liquid
phase separated condensates, chromosomes and single
cells30,32,35–37. As fundamental achievement, we have recently
demonstrated that ORS-nanoIR enables to acquire IR absorption
spectra for secondary structure determination from single protein
molecules38.
In the present work, we exploit the powerful combination of
single-molecule imaging and vibrational spectroscopy offered by
AFM-IR to characterise at the single aggregate scale the
morphological, chemical and structural properties of the aggre-
gated species of Aβ42 in the absence and the presence of bexar-
otene. We thus provide a direct measurement at the single
oligomeric scale of the interactions between a small molecule and
Aβ42 oligomers and fibrils. Our results constitute a key finding in
the investigation of the transient and heterogeneous conforma-
tional changes occurring during protein aggregation as well as the
capability to study the interactions between proteins and ther-
apeutic compounds, with the aim of developing therapeutics
against neurodegenerative disorders.
Results
Bexarotene inhibits Aβ42 aggregation. Before investigating the
chemical interactions between bexarotene and Aβ42 aggregates at
the nanoscale, we carried out a characterisation of the aggregation
process of Aβ42 (Fig. 1). As shown by phase-controlled high-
resolution AFM imaging, before incubation at 0 h, Aβ42 is largely
in a monomeric state and there are no fibrillar aggregates visible
(Fig. 1a). After 4 h incubation, as previously reported, we observe
an abundance of fibrillar aggregates with typical cross-sectional
diameters between 2 and 6 nm (Supplementary Fig. 1). We fur-
ther performed a kinetic analysis of the aggregation of Aβ42 using
a highly reproducible ThT-based protocol39. In particular, we
investigated the aggregation reaction in the absence and the
presence of threefold excess of bexarotene and one of its deri-
vatives where the carboxyl group was substituted by an ester
functional group, leading to the absence of an acidic ionisable
group (Fig. 1c and Supplementary Figs. 2 and 3). The rationale
behind the choice of this derivative is based on our previous
experiments that have systematically assessed how different
modifications of the hydrophilic and hydrophobic parts of the
bexarotene scaffold affect the kinetics of aggregation of Aβ4240.
The aggregation displays the three phases of a typical nucleation-
polymerisation reaction: lag, growth and plateau. Indeed, typical
amyloid formation displays sigmoidal growth kinetics, where a
transition zone, namely the growth phase, is preceded and fol-
lowed by flat regions, usually referred to as the lag phase and the
plateau, respectively. Bexarotene delayed the aggregation of
Aβ42 significantly, by inhibiting both primary and surface-
catalysed secondary nucleation as previously demonstrated21. On
the other hand, its derivative did not affect the aggregation
reaction even at high concentrations. These results show that
bexarotene can slow down the kinetics of aggregation reaction
through a direct interaction with Aβ42 aggregates.
Infrared nanospectroscopy of single Aβ42 oligomers and
fibrils. We first applied conventional bulk IR spectroscopy to
investigate the chemical binding between Aβ42 fibrils formed at
the end of the aggregation reaction (plateau phase, 4 h) and
bexarotene (Supplementary Fig. 4). However, with bulk IR
spectroscopy, we were not able to observe any difference between
the fibrils formed in presence and absence of bexarotene, and thus
we could not study their chemical binding using conventional
FTIR. This limitation is largely related to the nature of this bulk
technique, which is not able to discriminate between bound small
molecules and the ones diffused in solution.
To overcome these limitations, we next exploited the nanoscale
chemical resolution power of AFM-IR to study the chemical and
structural properties of Aβ42 aggregates at the single molecule
scale (Fig. 1d–e) in the absence and presence of bexarotene.
Consequently, ThT-free aliquots of Aβ42 solutions were removed
at different time points from the aggregation reactions for single-
molecule measurements. In particular, we focused on the growth
phase around the half-time of the reactions (2 h for Aβ42 alone
and 4.5 h for Aβ42+bexarotene) and on the plateau phase of
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aggregation after 15 h incubation. We deposited the aliquots of
Aβ42 aggregates on atomically flat (0.4 nm RMS) template gold
surfaces. As expected, in the growth phase we observed the co-
existence of oligomeric and fibrillar aggregates, while in the
plateau phase we observed only fibrillar aggregates (Fig. 2a, b and
Supplementary Fig. 5), similarly as observed for samples
deposited on conventional mica substrates (Fig. 1).
Then, we focused on the measurement of the single aggregate
chemical and structural properties of Aβ42 aggregates alone. The
sensitivity of AFM-IR has been recently demonstrated to be
capable to reach the detection of single protein molecules of
apoferritin with a molecular weight of ~400 kDa and hydro-
dynamic radius of ~12 nm, with high signal-to-noise ratio in
order to determine their secondary structure38. This high
sensitivity was reached by measuring at a short laser pulse, off-
resonance (ORS-nanoIR)38 and exploiting the field enhancement
at the nanogap with the metallic probe and substrate and reach
single protein molecule sensitivity. We applied similar principles
in the present study to reach the detection of the chemical
signature of individual oligomeric (Fig. 2c) and fibrillar species of
Aβ42 (Fig. 2d) with a typical cross-sectional diameter of both
oligomeric and fibrillar ranging between ~3 and 8 nm (Supple-
mentary Fig. 6). To exclude from our chemical and structural
analysis the residual absorption of contaminants on the tip and
on the substrate, we subtracted each spectrum acquired on one
aggregate from the residual absorption on the substrate
(Supplementary Fig. 7).
We then applied second derivative analysis to deconvolve the
amide band I of the aggregates and evaluate the structural
contributions to their secondary and quaternary structure (Fig. 2e,
f). The oligomeric aggregates presented their major structural
contribution at 1648 cm−1, indicating the prevalence of random coil
conformation, but also a significant peak at 1695 cm−1 indicating the
presence of intermolecular antiparallel β-sheets (Fig. 2e). In the case
of the fibrillar aggregates, we could observe the presence of both a
high frequency band (1695 cm−1) and a low-frequency band (1630
cm−1) associated with intermolecular β-sheet (Fig. 2f), which in the
case of Aβ42 together indicate a structural shift to a parallel β-sheet
arrangement41–44. These results demonstrate at the single aggregate
scale the conversion step from an antiparallel β-sheet conformation
in oligomeric species to a parallel β-sheet conformation in the fibrillar
products of the aggregation kinetics45. In the case of the oligomers,
their cross-sectional diameter (~5–8 nm) and volume was below the
size of a single protein molecule of apoferritin (~12 nm), which was
only very recently achieved38. Although we could reach this high
sensitivity, the measurement of the spectra of the oligomers was at
the limit of the experimental sensitivity leading to a higher
experimental noise and a partial suppression of the amide band II,
as observed for single proteins previously38.
Interaction of single oligomers and fibrils with bexarotene. We
next applied AFM-IR to unravel the chemical interaction and
effect of bexarotene on the aggregated species of Aβ (Fig. 3). We
acquired first AFM morphology maps of single oligomeric
(Fig. 3a) and fibrillar (Fig. 3b) species formed during the kinetics
of aggregation in the presence of bexarotene. The aggregates
showed similar morphology and cross-sectional dimensions as
Fig. 1 Effect of bexarotene on the aggregation kinetics of Aβ42. a Representative high-resolution AFM morphology maps of Aβ42 aggregates before
incubation (0 h) and at the end of the aggregation reaction (4 h). The morphology of the aggregates was reproducible and consistent on at least five
independent and randomly chosen areas on the surface of each sample. b Structures of bexarotene and its derivative, where the hydroxyl group is replaced
with a methyl group (highlighted in red). c Kinetics profiles of the aggregation reaction of 2 μM Aβ42 in the absence or in the presence of a 3:1
concentration ratio of bexarotene or its derivative. The solid lines show the best fit of the experimental data (open circles) when primary and secondary
pathways are both inhibited by bexarotene. d, e Schematic of the AFM-IR experimental approach to study the interaction of Aβ42 oligomers (light blue
sphere) and fibrils (dark blue rod) with bexarotene (green star) at the single aggregate scale. To reach high sensitivity off-resonance, small pulse ORS-
nanoIR at the nanogap between a gold-coated probe and a gold substrate was used38.
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the ones in absence of the small molecule (Supplementary Fig. 5).
Then, we acquired nanoscale resolved spectra from both oligo-
meric and fibrillar species incubated in the presence of bexarotene
(Fig. 3c, d). The spectra of the aggregates in the presence of
bexarotene showed marked differences when compared to the
spectra of the aggregates incubated in the absence of the small
molecule. In particular, we observed a significantly increased
absorption between 1750–1700 and 1425–1475 cm−1 (green
boxes in Fig. 3c, d). The nanoscale localised spectra showed only
minor differences in the region of the amide I band (1700–1600
cm−1), thus indicating that the fibrillar aggregates unbound and
bound to bexarotene had similar secondary structure, in good
agreement with the morphological observations (Supplementary
Fig. 6). In order to prove that the spectral differences measured
between aggregated species in the presence and absence of
bexarotene were statistically significant, we further performed a
principal components analysis (PCA; Fig. 3e–g).
PCA allowed noise reduction and the detection of subgroup-
ings within the spectra of the aggregates in the presence and
absence of bexarotene. The score plots of the analysis (Fig. 3e, f)
represent each single nanoscale resolved IR spectrum as a point in
the multidimensional space of principal components (PCs). The
first three PCs were sufficient to represent more than 85% of the
spectra variability in the ensemble and demonstrate the high
statistical significance of the subgrouping (Fig. 3e) of the
spectroscopic signature of the aggregates formed in the absence
(blue) and presence (red) of bexarotene. The spectral differences
represented by each principal component are shown in the
loading plots (Fig. 4g and Supplementary Fig. 8), which show the
spectroscopic region responsible for the greatest degree of
Fig. 2 Single molecule measurements of secondary and quaternary structure of Aβ42 aggregates. a, b AFM-IR morphology maps of single oligomeric
(light blue sphere) (a) and fibrillar species (dark blue rod) (b) of Aβ42. The morphology of the aggregates was reproducible and consistent on at least five
independent and randomly chosen areas on the surface of each sample. c, d Nanoscale localised IR absorption spectra of oligomeric (c) and fibrillar species
(d) of Aβ42. We represent two spectra: (i) the average+ SE of the raw spectra and (ii) the average+ SE of the preprocessed spectra by applying an
adjacent averaging filter (5 pts) and a Savitzky–Golay filter (second order, 15 pts). At least five different raw spectra at each position (coloured crosses)
were acquired. e, f The second derivatives of the spectra are calculated with a Savitzky–Golay filter (second order, 15 pts) to deconvolve the major
secondary structural contributions of the oligomeric and fibrillar species.
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Fig. 3 Structural characterisation of the interaction of bexarotene with single Aβ42 oligomers and fibrils. AFM-IR morphology maps a oligomeric (light
blue sphere) and b fibrillar species (dark blue rod). The morphology of the aggregates was reproducible and consistent on at least five independent and
randomly chosen areas on the surface. Nanoscale localised IR absorption spectra (c, d) of oligomeric (a, c) and fibrillar species (b, d) of Aβ42 incubated
with bexarotene (Bex). We represent two spectra: (i) the average+ SE of the raw spectra and (ii) the average+ SE of the preprocessed spectra by
applying an adjacent averaging filter (5 pts) and a Savitzky–Golay filter (second order, 15 pts). At least five different raw spectra at each position (coloured
crosses) were acquired. e, f 3-D and 2-D score plots of PCA analysis applied to Aβ42 aggregates (oligomers and fibrils, n= 40) in the absence of
bexarotene (blue), Aβ42 aggregates in the presence of bexarotene (oligomers and fibrils, n= 31, red) and bexarotene alone (n= 9, green). The coloured
ellipsoids represent the 90% confidence of the variance of each group, thus demonstrating the separation of the spectroscopic signature of the aggregates
in presence and absence of bexarotene. g Loading plots of the PC1 and PC2.
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separation inside between the spectra sub-groups. The first two
PCs were sufficient to generalise the spectral differences (>80%
spectral difference). A negative PC1 and PC2 were correlated with
the chemical signature of the characteristic amide bands I
(1700–1600 cm−1) and II (1580–1500 cm−1) of protein, dom-
inating the spectra in the absence of bexarotene. While positive
PC1 and PC2 were correlated with the chemical signature of
bexarotene at 1700–1750 cm−1 (C=O), 1580 and 1450 cm−1
(C–O) (Fig. 4a). As expected, the spectra of the aggregates in
presence of bexarotene (red) had mixed grouping properties
when compared with the IR absorption signature of the small
molecule (green) and the aggregates alone (blue). Thus, the
analysis demonstrates with high statistical significance the
presence of the chemical signature of bexarotene within the
Aβ42 aggregates incubated with the molecule.
Bexarotene interacts with Aβ42 aggregates through H-
bonding. The increased IR absorption in the spectra of the
aggregates incubated with bexarotene showed two main peaks of
absorption at 1750–1700 and 1450 cm−1 (Fig. 3c, d), related to
the vibrations of the C=O and C–O bonds of the small molecule
alone (Fig. 4a). Bexarotene alone in solution has strong tendency
to be in a dimeric form through a bidentate coordination
(Fig. 4b), thus showing a typical frequency of the C=O bond at
approximately 1690 cm−1, as previously shown in literature in the
similar case of benzoic acid and its derivatives46. As shown by the
average spectra in Fig. 4c and in the loading plots of PCA (red
arrows in Fig. 3g and Supplementary Fig. 8), the C=O peak of
bexarotene in the presence of the aggregates is significantly
shifted to higher wavenumbers (~1730 cm−1). This chemical shift
demonstrates that bexarotene is transitioning from a dimeric
form with double coordination to a monomeric form coordi-
nating with the amyloid aggregates through hydrogen bonding,
thus causing the shift of the carbonyl peak of bexarotene to higher
energies (Supplementary Fig. 9)47. This difference is also
demonstrated by comparing the experimental spectra of the
fibrillar aggregates incubated with bexarotene and the calculated
spectrum obtained summing the spectroscopic response of the
fibrils and the small molecule alone (Supplementary Figs. 9 and
10). The two spectra differ significantly in the region of the
carbonyl group of the carboxyl group and the N–H bond of the
protein, which are involved in hydrogen bonding, thus demon-
strating that these chemical bonds are involved in the
protein–small molecule interaction. The main possible mechan-
isms of hydrogen bonding (Supplementary Fig. 9) is the direct
interaction of the carboxyl group with the protein backbone
(Fig. 4d). The C=O bond of the carboxyl group of the small
molecule can form a hydrogen bond with the N–H of the protein
backbone (red circle in Fig. 4d) or the OH group of the molecule
Fig. 4 Bexarotene interacts with Aβ42 aggregates through hydrogen bonding of its carboxyl group. a AFM-IR spectrum of a bexarotene (Bex, green)
film deposited on a gold substrate. We represent two spectra: (i) the average+ SE of the raw spectra (n= 12), and (ii) the average+ SE of the
preprocessed spectra (n= 12) by applying an adjacent averaging filter (5 pts) and a Savitzky–Golay filter (second order, 15 pts). Five different raw spectra
at each position (coloured crosses) were acquired. b Bexarotene alone has strong tendency to form dimers stabilised by two hydrogen bonds
corresponding to a C=O IR absorption at 1690 cm−1, compared to the 1720–1745 cm−1 range of bexarotene forms with one hydrogen bond
(Supplementary Fig. 9)47. c Aβ42 fibrils show the typical spectrum of proteins (blue), while fibrils incubated with bexarotene (red) show an additional
chemical signature related to the small molecule and with a frequency of absorption at ~1725 cm−1, demonstrating that bexarotene is in the monomeric
form and interacting with the fibrils through a single hydrogen bonding (red or orange). d Schematic of the fibril (blue) and bexarotene (green stars)
interaction through hydrogen bonding. When bonded with the fibril or oligomer, bexarotene is likely to assume a conformation such that its bulky part is
projected away from the nearest amino acid side chains.
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can form a hydrogen bond with the C=O group of the protein
backbone (orange circle in Fig. 4d). Further possible interactions
would be hydrogen bonding with the charged amino acids side
chains of the Aβ42 protein, such as, glutamic acid, aspartic acid,
arginine, lysine and histidine48. Other possible interactions
between the carboxyl group and the protein are disfavoured due
to molecular bulkiness, steric hindrance and the relatively long
distance between two consecutive parallel amide hydrogens in the
polypeptide chain.
In summary, the analysis of the spectra demonstrates that the
hydrophilic moiety of bexarotene, specifically its carboxyl group,
binds through hydrogen bonding to Aβ42 aggregates (Fig. 4d).
Since the bexarotene derivative containing a methyl ester group
does not modify the kinetics of Aβ42 aggregation, these results
indicate that inhibiting aggregation requires the stronger and
longer range hydrogen bonding of the carboxyl group over the
weaker hydrogen bond of the methyl ester group (Fig. 1c)49.
Furthermore, the inability of the bexarotene methoxy derivative
to inhibit the aggregation pathway of Aβ42 may be related to
other differences with the bexarotene molecule, such as the
presence of the methyl group preventing the C=O interaction
and a different ionisation state (pKa) of the carboxyl group in
these two molecules.
Discussion
In this study, we applied IR nanospectroscopy in combination
with multivariate data analysis to first study the secondary
structure of Aβ42 oligomeric and fibrillar amyloid species at the
single aggregate scale, and then prove their chemical interactions
with a small-molecule inhibitor of Aβ42 aggregation with single
bond resolution. Initially, we characterised the aggregates of
Aβ42, proving a transition from antiparallel to parallel inter-
molecular β-sheet content when going from the oligomeric to the
fibrillar state. Then, we demonstrated that the small molecule
binds through its hydrophilic moiety to Aβ42 aggregates mainly
through a hydrogen bond made by its carboxyl group. These
results demonstrate that IR nanospectroscopy enables the iden-
tification at atomic level of the interactions between a small
molecule and its target, which has been to date hindered for Aβ42
aggregates due their transient and heterogeneous nature. We
therefore anticipate that the use of IR nanospectroscopy in drug
discovery will open the way to systematic structure–activity
relationship studies in compound optimisation campaigns.
In conclusion, this work establishes IR nanospectroscopy as a
powerful tool for characterising interactions of drugs with protein
aggregates at the single oligomer level, and identifying key
interaction signatures. More broadly, the development of single-
molecule biophysical methodologies represents a fruitful avenue
to address the challenge of unravelling the interaction of ther-
apeutic compounds with aggregating proteins, such as small
molecules, as well as antibodies. Such a molecular level under-
standing is key for establishing rational approaches to prevention
and design pharmacological approaches to misfolding diseases.
Methods
Aβ peptides. The recombinant Aβ(M1–42) peptide (MDAEFRHDSGY EVHHQ
KLVFF AEDVGSNKGA IIGLMVGGVV IA), here called Aβ42, was expressed in
the Escherichia coli BL21 Gold (DE3) strain (Stratagene, CA, USA) and purified39.
The purification procedure involved sonication of E. coli cells, dissolution of
inclusion bodies in 8M urea, and ion exchange in batch mode on diethylami-
noethyl cellulose resin and lyophylization. The lyophilised fractions were further
purified using Superdex 75 HR 26/60 column (GE Healthcare, Buckinghamshire,
UK) and eluates were analysed using SDS-PAGE for the presence of the desired
protein product. The fractions containing the recombinant protein were combined,
frozen using liquid nitrogen and lyophilised again. Bexarotene was obtained from
Sigma-Aldrich, while the derivative of bexarotene was obtained from ArkPharm
and both were of the highest purity available.
Sample preparation for kinetic experiments. Solutions of monomeric peptides
were prepared by dissolving the lyophilised Aβ42 peptide in 6 M GuHCl. Mono-
meric forms were purified from potential oligomeric species and salt using a
Superdex 75 10/300 GL column (GE Healthcare) at a flowrate of 0.5 ml/min, and
were eluted in 20 mM sodium phosphate buffer, pH 8 supplemented with 200 μM
EDTA and 0,02% NaN3. The centre of the peak was collected and the peptide
concentration was determined from the absorbance of the integrated peak area
using ε280= 1490 l/mol cm. The obtained monomer was diluted with buffer to the
desired concentration and supplemented with 20 μM Thioflavin T (ThT) from a
2 mM stock. All samples were prepared in low-binding eppendorf tubes on ice
using careful pipetting to avoid introduction of air bubbles. Each sample was then
pipetted into multiple wells of a 96-well half-area, low-binding, clear bottom and
PEG-coating plate (Corning 3881), 80 μl per well, in the absence and the presence
of bexarotene.
Kinetic assays. Assays were initiated by placing the 96-well plate at 37 °C under
quiescent conditions in a plate reader (Fluostar Omega, Fluostar Optima or
Fluostar Galaxy, software version 5.4, BMGLabtech, Offenburg, Germany). The
ThT fluorescence was measured through the bottom of the plate with a 440 nm
excitation filter and a 480 nm emission filter. The ThT fluorescence was followed
for three repeats of each sample, which were fully consistent and reproducible.
Theoretical analysis. The time evolution of the total fibril mass concentration, M
(t), is described by the following integrated rate law22,50:
MðtÞ








To capture the complete assembly process, only two particular combinations of
the rate constants define most of the macroscopic behaviours. These are related to
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, where the initial
concentration of soluble monomers is denoted by m(0), nc and n2 describe the
dependencies of the primary and secondary pathways on the monomer
concentration, and kn, k+ and k2 are the rate constants of the primary nucleation,
elongation and secondary nucleation, respectively. Using Eq. (1), the experimental
data of the aggregation of Aβ42 in the absence and presence of bexarotene can be
described via a concomitant decrease in both kn and k2.
FTIR measurements. Attenuated total reflection infrared spectroscopy (ATR-
FTIR) was performed using a Bruker Vertex 70 spectrometer equipped with a
diamond ATR element and spectra were collected by the built-in software OPUS
(version 8.2, Bruker, USA). Two micromolar samples of Aβ42 aggregates in the
absence and presence of threefold excess were centrifuged and re-suspended in
buffer to a final concentration of 2 mM. Spectra were acquired with a resolution of
4 cm−1 and all spectra were processed using Origin Pro 2019 software. The spectra
were averaged (3 spectra with 512 co-averages), smoothed applying a
Savitzky–Golay filter (second order, 9 pts). The FTIR measurements were per-
formed for three independent samples, which were fully consistent and
reproducible.
Atomic force microscopy. AFM was performed on positive functionalized mica
substrates. We cleaved the mica surface and we incubated it for 1 min with 10 µl of
0.5% (v/v) (3-aminopropyl)triethoxysilane (APTES, from Sigma) in Milli-Q water.
Then, the substrate was rinsed three times with 1 ml of Milli-Q water and dried by
gentle stream of nitrogen gas. Finally, for each sample, an aliquot of 10 µl of the
solution was deposited on the functionalized surface. The droplet was incubated for
10 min, then rinsed by 1 ml of Milli-Q water and dried by the gentle stream of
nitrogen gas. The preparation was carried out at room temperature. AFM maps
were acquired by means of an NX10 and its built-in software XEI (version 4.3.4,
Park systems, South Korea) operating in tapping mode and equipped with a silicon
tip (μmasch, 2 N/m) with a nominal radius of ~8 nm. Image flattening and single
aggregate cross-sectional dimension analysis were performed by SPIP (Version
7.3.4, Image Metrology) software.
AFM-IR measurements, maps treatment and analysis. Analysis by nanoIR2
(Anasys Instrument, USA) was performed on atomically flat and positive gold
substrates with a nominal roughness of 0.36 nm (Platypus Technologies, USA)51.
The root mean square roughness of the AFM maps was measured by SPIP
(Image metrology, Denmark). To prepare the protein samples, an aliquot of 10 µl
of sample was deposited on the flat gold surface for 30 s, to reduce mass
transport phenomena during drying. Successively, the droplet was rinsed by 1 ml
of Milli-Q water and dried by a gentle stream of nitrogen. The morphology of
the protein samples was scanned by the nanoIR microscopy system, with a rate
line within 0.1–0.5 Hz and in contact mode. All AFM maps were acquired with a
resolution between 2 and 10 nm/pixel. A silicon gold-coated PR-EX-nIR2
(Anasys, USA) cantilever with a nominal radius of ~30 nm and an elastic con-
stant of about 0.2 N/m was used. To use gold–gold rod-like antenna effect the IR
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light was polarised perpendicular to the surface of deposition. The AFM images
were treated and analysed using SPIP software. The height images were first and
second order flattened. Spectra were collected with a laser wavelength sampling
of 2 cm−1 with a spectral resolution of ~1 cm−1 and 256 co-averages, within the
range 1400–1800 cm−1. The spectra were acquired at a speed of 60 cm−1 s−1. All
spectra and maps were acquired at the same power of background laser power,
between approximately 0.35 and 1 mW and with a pulse width between 40 and
100 ns. Since the spectral background line shape slightly depends on laser power,
the spectra were normalised by the QCL emission profile by the built-in Analysis
Studio software (version 3.15). The chemical maps and spectra were acquired on
randomly chosen aggregates on each sample’s surface. All measurements were
performed at room temperature under controlled nitrogen atmosphere with
residual real humidity below 5%. The spectra were acquired by using measuring
off-resonance by ORS-nanoIR, on the left of the IR amplitude maximum reso-
nant frequency36,52,53.
Spectra analysis and statistical significance. Spectra were analysed using the
microscope’s built-in Analysis Studio (version 3.15, Anasys, USA) and OriginPRO.
On each protein aggregate with/without small molecule at least 3 AFM-IR spectra
were co-averaged, in order to have a standard error of the average in the order 5%.
The spectra where despiked, an adjacent averaging filter (5 pts) and a
Savitzky–Golay filter (15 pts, second order) were applied in series and then the
spectra were normalised to one respect to the maximum of intensity. The structural
contributions were investigated by second derivative analysis to deconvolution of
the amide band I25,27,54. The second derivatives were smoothed by a
Savitzky–Golay filter (second order, 7 pts).
For the PCA, the spectra were smoothed and normalised spectra, as described
above, and further baselined to zero in the range 1400–1800 cm−1. PCA was
performed by means of OriginPRO 2019 by considering a mean-centred covariance
matrix. A total of 71 spectra was sufficient to detect the subgrouping of the spectra
of the aggregates incubated with/without the small-molecule bexarotene, out of the
90% confidence of the variance of each group. In all cases the first three PCs
accounted for more than 85% of spectral variance. AFM-IR measurements were
performed on five independent samples; several independent aggregates were
measured (oligomers n= 8 and fibrils n= 20).
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
All data needed to evaluate the conclusions of the paper are present in the paper and
the Supplementary Information file. Other data are available from the corresponding
author upon request. Source data are provided with this paper.
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